Fifth European progress in vaccination against cancer conference, PIVAC 5.
Cavallo
Federica
F
Department of Clinical and Biological Sciences, University of Turin, Ospedale San Luigi Gonzaga, 10043 Orbassano, Italy. federica.cavallo@unito.it
Baxevanis
Constantin N
CN
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D001943:Breast Neoplasms / Q000628:therapy; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D018734:Genes, erbB-2; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007167:Immunotherapy / Q000379:methods; D019169:Jurkat Cells; D008545:Melanoma / Q000235:genetics / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D009857:Oncogenes; D034741:RNA, Small Interfering / Q000627:therapeutic use; D051381:Rats; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D051603:Recoverin / Q000276:immunology; D016896:Treatment Outcome; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000276:immunology
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D006680:HLA Antigens; D034741:RNA, Small Interfering; D018719:Erb-b2 Receptor Tyrosine Kinases; D011948:Receptors, Antigen, T-Cell; D051603:Recoverin; D014614:Vaccines, Synthetic